Why the study?
Patients with NAFLD are at increased risk of vascular events, but the relationship between pancreatic fat accumulation and markers of atherosclerosis in this population was unclear.
Does the presence of nonalcoholic fatty pancreas disease (NAFPD) increase carotid intima media thickness (cIMT) in patients with nonalcoholic fatty liver disease (NAFLD)?
Does the presence of nonalcoholic fatty pancreas disease (NAFPD) increase carotid intima media thickness (cIMT) in patients with nonalcoholic fatty liver disease (NAFLD)?
In patients with NAFLD, the presence of pancreatic fat accumulation is independently associated with increased carotid intima media thickness, suggesting a higher risk of early atherosclerosis.
Pancreatic fat in NAFLD may associate with atherosclerosis markers; leaves open incremental value beyond hepatosteatosis for risk prediction.
We investigated the relationship between pancreatic fat accumulation and markers of atherosclerosis among patients with nonalcoholic fatty liver disease (NAFLD). Patients with NAFLD have been reported to be at an increased risk of vascular events. We grouped 183 patients in whom we detected and graded hepatosteatosis (HS) on transabdominal ultrasonography into 2 groups based on the presence/absence of pancreatic fat. There were 85 participants (50 female; mean age: 53.6 ± 9.7 years) who were nonalcoholic fatty pancreas disease (NAFPD) positive and 98 participants (56 female; mean age: 51.4 ± 9.3 years) who were NAFPD negative. Carotid intima media thickness (cIMT) was significantly greater in the group where HS was accompanied by NAFPD (0.51 [0.40–0.62] vs 0.45 [0.35–0.55] mm; P < .001). Multivariable analyses showed that the independent predictors of increased cIMT were age (odds ratio [OR]: 1.108; 95% CI: 1.059–1.158, P = .001), hypertension (OR: 2.244; 95% CI: 1.099–4.579, P = .026), and the presence of NAFPD (OR: 3.078; CI 95% CI: 1.531–6.190, P = .0002). In the present study we demonstrated that, in patients with NAFLD, pancreatic fat accumulation was significantly associated with cIMT, a marker of early atherosclerosis. NAFPD may increase the risk of vascular events associated with NAFLD.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: